Prediabetes

Metabolic Diseases
0
Pipeline Programs
5
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
BottargaN/A1 trial
Active Trials
NCT06988462Recruiting20Est. Dec 2026
Abbott
AbbottABBOTT PARK, IL
1 program
GEMN/A1 trial
Active Trials
NCT05580978Completed40Est. Jan 2025
M&
Merck & Co.RAHWAY, NJ
1 program
Oral glucose toleranceN/A1 trial
Active Trials
NCT02229487Completed51Est. Mar 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsBottarga
AbbottGEM
Merck & Co.Oral glucose tolerance

Clinical Trials (3)

Total enrollment: 111 patients across 3 trials

NCT06988462Alliance PharmaceuticalsBottarga

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

Start: Oct 2025Est. completion: Dec 202620 patients
N/ARecruiting
NCT05580978AbbottGEM

CGM Plus GEM in Prediabetes

Start: Nov 2022Est. completion: Jan 202540 patients
N/ACompleted
NCT02229487Merck & Co.Oral glucose tolerance

The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers

Start: Oct 2014Est. completion: Mar 201751 patients
N/ACompleted

Related Jobs in Metabolic Diseases

Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV

Amgen
California - San Francisco, US
20h ago

(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)

Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday

Computational Chemist

Topos Bio
San Francisco Office
2d ago

Associate Director, Legal Operations & Contracts Management

Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr

Senior Specialist, Quality Management Systems

Crinetics Pharmaceuticals
San Diego, CA
4d ago
$91K - $114K/yr

Director, Quality Systems, Project Management, QRM, RS

Crinetics Pharmaceuticals
US California
4d ago
$178K - $223K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 111 patients
5 companies competing in this space

Related Indications

Diabetes(737)Diabetes Mellitus, Type 2(485)Obesity(246)Type 2 Diabetes(207)Type 2 Diabetes Mellitus(190)Diabetes Mellitus(127)Diabetes Mellitus, Type 1(95)Type 1 Diabetes Mellitus(51)Type 1 Diabetes(50)Dyslipidemia(45)